Skip to search formSkip to main contentSkip to account menu

Levosimendan

Known as: Levosimedan, Levosimendanum 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Background and Objectives To explore the lung-protective effect of levosimendan (LS) during cardiopulmonary bypass in a canine… 
2015
2015
BACKGROUND The aim of this study was to evaluate the histological and immunohistochemical effects of levosimendan on liver injury… 
2014
2014
BACKGROUND Recent reports demonstrated that levosimendan improved post-resuscitation myocardial function in rat and pig models… 
2012
2012
AIM To evaluate the efficiency and safety of intravenous infusion of levosimendan in patients with idiopathic pulmonary… 
2010
2010
OBJECTIVES Unlike traditional inotropic agents, levosimendan is thought to have a lower potential to induce arrhythmias because… 
2009
2009
Currently, prostacyclin, endothelin receptor antagonists and phosphodiesterase inhibitors are recommended therapy in idiopathic… 
2008
2008
Background and objective: Levosimendan has a cardioprotective action by inducing coronary vasodilatation and preconditioning by… 
2003
2003
There are 2 studies which have investigated the hemodynamic efficacy of levosimendan compared to dobutamine in congestive heart… 
2003
2003
: Levosimendan, is a new calcium sensitiser with 2 major effects. First, levosimendan acts as a positive inotropic agent by… 
1995
1995
Levosimendan belongs to a new group of heart failure drugs, the calcium sensitizers. Because these compounds are not yet…